Distillate Capital Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$63.6M |
| 2 |
Johnson & Johnson
JNJ
|
+$50.9M |
| 3 |
AbbVie
ABBV
|
+$48.3M |
| 4 |
T-Mobile US
TMUS
|
+$39.8M |
| 5 |
Comcast
CMCSA
|
+$37.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MRO
Marathon Oil Corporation
MRO
|
+$15K |
| 2 |
Westlake Corp
WLK
|
+$14.5K |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$14.4K |
| 4 |
Microchip Technology
MCHP
|
+$13.8K |
| 5 |
Snap-on
SNA
|
+$13.6K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.25% |
| 2 | Healthcare | 20.84% |
| 3 | Industrials | 19.17% |
| 4 | Consumer Discretionary | 16.46% |
| 5 | Communication Services | 5.88% |
Similar funds
Distillate Capital Partners's Q2 2024 Portfolio in Review
As of Q2 2024, Distillate Capital Partners held 114 positions worth $1.89B, up 317,289% from $595K the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Distillate Capital Partners deployed $1.92B of net new capital in Q2 2024, opening 73 new positions and adding to 31 existing holdings. Its largest new stake was Johnson & Johnson: 342,177 shares worth $50M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 14% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the most notable exit was Marathon Oil Corporation, an estimated $15K sold.
- Distillate Capital Partners's largest Q2 2024 buy was Johnson & Johnson: 342,177 shares worth $50M.
- Distillate Capital Partners added most to UnitedHealth in Q2 2024, an estimated $63.6M increase.
- Distillate Capital Partners fully exited Marathon Oil Corporation in Q2 2024, selling an estimated $15K.
- Distillate Capital Partners's ten largest holdings make up 22% of its $1.89B portfolio in Q2 2024.
- Distillate Capital Partners opened 73 new positions and closed 10 in Q2 2024.
- Distillate Capital Partners's portfolio value rose 317,289% quarter-over-quarter to $1.89B.
Based on Distillate Capital Partners's 13F filing for Q2 2024, filed 14 Aug 2024.